Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis initial report

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 PART I, 1998, Pages 1726-1733

  Tam, C M ^c   Chan, S L ^c   Lam, C W ^c   Leung, C C ^c   Kam, K M ^c   Morris, J S ^a   Mitchison, D A ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; SPUTUM CULTURE; THORAX RADIOGRAPHY; VERTIGO; VOMITING;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PYRAZINAMIDE; RIFAMPIN; STREPTOMYCIN; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 0031807468     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.9707037     Document Type: Article

References (18)

1. Fox, W. 1971. General considerations in intermittent drug therapy of pulmonary tuberculosis. Postgrad. Med. J. 47:729-736.
2. Dhillon, J., J. M. Dickinson, J. A. Guy, T. K. Ng, and D. A. Mitchison. 1992. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis. Tubercle Lung Dis. 73:116-123.
3. Truffot-Pernot, C., J. Grosset, R. Bismuth, and H. Lecoeur. 1983. Activity of intermittent rifampicin and cyclopentylrifamycin (DL473) in experimental murine tuberculosis. Rev. Fr. Mal. Respir. 11:875-882.
4. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. Tubercle 68:113-118.
5. Chan, S. L., W. W. Yew, J. H. D. Porter, K. P. W. J. McAdam, B. W. Allen, J. M. Dickinson, G. A. Ellard, and D. A. Mitchison. 1994. Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals. Int. J. Antimicrob. Agents 3:267-274.
6. Tam, C. M., S. L. Chan, C. W. Lam, J. M. Dickinson, and D. A. Mitchison. 1997. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Int. J. Tuberc. Lung Dis. 1:411-416.
7. National Co-ordinating Group for Clinical Study of DL-473. 1987. Controlled clinical trial of cyclopentyl rifamycin in treatment for pulmonary tuberculosis. Chin. J. Antibiot. 12:321-328.
8. National Co-ordinating Group for Clinical Study of DL-473. 1992. A controlled clinical trial of DL473-containing chemotherapy regimens for bacillary tuberculosis - results at three years. Clin. J. Antibiot. 17:322-332.
9. Ellard, G. A., and C. Greenfield. 1977. A sensitive urine-test method for monitoring the ingestion of isoniazid. J. Clin. Path. 30:84-87.
10. Mitchison, D. A., B. W. Allen, and A. B. Miller. 1970. Detection of rifampicin in urine by a simple microbiological assay. Tubercle 51:300-304.
11. East African/British Medical Research Councils. 1960. Comparative trial of isoniazid in combination with thiacetazone or a substituted diphenylthiourea (SU 1906) or PAS in the treatment of acute pulmonary tuberculosis in East Africans. Tubercle 41:399.
12. Hong Kong Chest Service/British Medical Research Council. 1978. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. Am. Rev. Respir. Dis. 118:219-227.
13. Mitchison, D. A., and A. J. Nunn. 1986. Influence of initial drug resistance on the response short-course chemotherapy of pulmonary tuberculosis. Am. Rev. Respir. Dis. 133:423-430.
14. Hong Kong Chest Service/British Medical Research Council. 1991. Controlled trial of 2,4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Am. Rev. Respir. Dis. 143:700-706.
15. Singapore Tuberculosis Service/British Medical Research Council. 1975. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore. Lancet 2:1105.
16. Dhillon, J., and D. A. Mitchison. 1992. Activity and penetration of anti-tuberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254. J. Antimicrob. Agents Chemother. 33:1255-1259.
17. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis. Tubercle 68:183-193.
18. Ellard, G. A., and P. T. Gammon. 1977. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens. Br. J. Clin. Pharmac. 4:5-14.